LEVETIRACETAM INJECTION USP
LEVETIRACETAM INJECTION USP
Approved
DIN Number
02527375
Drug Class
Human
Market Date
Aug 5, 2022
Company
HC
Sterimax Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02527375
AIG Number0148843005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N03AX14 LEVETIRACETAM
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification28:12.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
LEVETIRACETAMActive
Strength: 100 MG / ML
Monograph: LEVETIRACETAM